Litigation Details for In re Xyrem (Sodium Oxybate) Antitrust Litigation (N.D. Cal. 2020)

In re Xyrem (Sodium Oxybate) Antitrust Litigation (N.D. Cal. 2020)

Docket		Date Filed	2020-12-16
Court	District Court, N.D. California	Date Terminated
Cause	15:15 Antitrust Litigation	Assigned To	Richard G. Seeborg
Jury Demand	Plaintiff	Referred To	Susan G. Van Keulen
Parties	HEALTH CARE SERVICE CORPORATION
Patents	10,213,400; 10,864,181; 6,780,889; 7,262,219; 7,668,730; 7,765,106; 7,765,107; 7,851,506; 7,895,059; 8,263,650; 8,324,275; 8,457,988; 8,589,182; 8,731,963; 8,772,306; 8,859,619; 8,952,062; 9,050,302; 9,486,426; 9,539,330
Attorneys	Matthew Perez
Firms	Zimmerman Reed, LLP
Link to Docket	External link to docket

Details for In re Xyrem (Sodium Oxybate) Antitrust Litigation (N.D. Cal. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-12-16				External link to document
2020-12-16	21	Joint Case Management Statement	. 10 25 U.S. Patent Nos. 6,472,431, 6,708,889, 7,262,219, 7,851,506, 8,263,650, 8,324,… 8 Patents”);10 (2) patents relating to safe methods of drug distribution (the “REMS Patents”);11 and… Formulation patents, REMS patents, and/or DDI patents; 17 10. Whether… Jazz manipulation of the patent system to acquire sham patents. Xyrem’s active ingredient, 2 …none of 3 Xyrem’s patents claim it. Instead, Jazz acquired multiple bogus patents claiming processes	External link to document
2020-12-16	62	Amended Complaint	2016 Mar. 15, 2033 21 10,213,400 Jan. 12, 2018 Feb. 26, 2019 …the ’219 patent, the ’730 patent, the 15 ’106 patent, and the ’107 patent. 16 150. On October… Simply owning a patent does not entitle the patent owner to exclude others. Patents 15 are routinely…acquired patent is not patentably 2 distinct from the invention claimed in an earlier patent (and no…and ’062 patents). 14 139. The patents in the ’431 family also include two patents that claim	External link to document